Digital technologies have already transformed the social fabric of life in the twenty-first century. They are now poised to profoundly influence clinical practice and healthcare. As a world-leader in musculoskeletal healthcare, Zimmer Biomet has always been exploiting new technologies to advance the pace of innovation. To take this commitment to the next level, Zimmer Biomet is announcing the
2nd Zimmer Biomet Connected Health Innovation Award
to advance the application of digital innovations in musculoskeletal healthcare. It comes with a financial prize of €25,000 and piloting and promoting opportunities across Europe.
The Zimmer Biomet Connected Health Innovation Award ("Award") is intended to accelerate the pace of innovation in the field of digital technologies in musculoskeletal health at large, and provide opportunities to pilot and launch digital innovations at Europe's leading hospitals. Applicants for the Award have to demonstrate an innovative technology-enabled solution targeting current and future needs in musculoskeletal healthcare. Eventually, the finalists will present their applications to a jury of renowned experts from industry and academia at the Zimmer Biomet EMEA headquarters in Winterthur (Switzerland). For all finalists, accommodation and travel costs for attending the finals event will be borne by Zimmer Biomet as described further below.
The Award application must be submitted by June 15th, 2018, and finalists will be announced by June 30th. The Finals will take place at Zimmer Biomet’s European HQ in Winterthur (Switzerland), in the 2nd week of July.
This is a unique chance for researchers, entrepreneurs and start-ups to present their work to renowned experts for feedback, and for opening up opportunities to accelerate the development and growth of their innovations.
The overall objective of the Award is to advance the use of digital technologies in musculoskeletal healthcare to help professionals and their patients’ progress to the next level. Eligible innovations should help to solve unmet needs in the treatment of musculoskeletal and orthopedic conditions (i.e. disorders of, or injuries to, the bones, joints, and supporting soft tissues).
Zimmer Biomet is specifically interested in digital solutions to address following challenges / pain points which hospitals which perform joint replacements typically face:
Applicants must have a market-ready product, have obtained any necessary regulatory approvals and should have first users willing to act as a reference (minimum 2-3 hospitals where a product has already been implemented and was used). The applicants must be able to demonstrate the value and core functionality of the products beyond concepts, papers, sketches, mockups, designs, formula and patents.
Special care should be taken to ensure that the proposed innovations solve real clinical problems and aim to reduce healthcare costs.
The Award is open to individuals, groups and organizations (including academia and industry).
The application needs to include a general description of the technology-enabled innovation (including pictures and videos). The application should further sketch the innovation that is proposed on a level of detail, which allows assessing the use of technology to address a particular unmet need in musculoskeletal healthcare in a novel way. Finally, it should provide some information on the economic impact of the proposed innovation. Furthermore, a short description of the individual, team or organization and its background should be provided.
The application has to be submitted online at www.connectedhealthaward.com by June 15th 2018, 23:59 CEST.
Please note: Any information that is provided will be regarded as, and deemed to be, non-confidential, and Zimmer Biomet shall have no obligation of any kind with respect to such information.
The applications will be reviewed by a jury composed of internationally renowned experts from industry and academia. The jury will select five finalists based on criteria described further below. By June 30th, 2018 Zimmer Biomet will announce the selected finalists.
The selected finalists will be invited to the Zimmer Biomet headquarters at Winterthur (Switzerland) to present their innovation and compete for the Award in the 2nd week of July. Zimmer Biomet covers accommodation and travel costs for up to three persons per team for this final event (up to the amounts specified below).
During the finals event, the winner of the Award and the €25,000 prize will be announced.
The main assessment criteria will be the level of innovation paired with the unmet need, and the level technological feasibility / readiness. Further criteria for the selection will be the originality of the overall approach, the expected economic impact of the suggested application and its competitive advantage. In addition, participants are encouraged to demonstrate scalability across European countries.
In particular, innovations will be judged for:
The Award application should address the following items:
Award applications are limited to twelve pages (including the cover page) addressing the items above in a balanced manner. Applicants are encouraged to provide video material as part of their application. Other supportive material, e.g. publications, should be linked to the application.
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. We design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. We collaborate with healthcare professionals around the globe to advance the pace of innovation. Our products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Together with healthcare professionals, we help millions of people live better lives. We have operations in more than 25 countries around the world and sell products in more than 100 countries.For more information, visit www.zimmerbiomet.com or follow Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet
You are eligible to enter the competition if you meet the following requirements at time of entry:
No transfer, substitution or cash equivalent for travel and accommodation grants, coaching, piloting or promotion of innovations is allowed, except at Zimmer Biomet’s sole discretion. Zimmer Biomet reserves the right to substitute a prize, in whole or in part, of equal or greater monetary value if a prize cannot be awarded, in whole or in part, as described for any reason. Each of the prize should not be construed or regarded as a personal gift and can only be used for the development and/or marketing of the Innovation. Should Zimmer Biomet become or be made aware of any violations of the principles referenced here, Zimmer Biomet reserves the right, after appropriate investigation of the matter, to withdraw its support with immediate effect and undertake such other steps as it may seem fit under the circumstances.
Applicants bear their own costs with the exception of costs explicitly listed here. Zimmer Biomet offers a travel and accommodation grant to reduce the financial burden of finalist teams traveling to Winterthur:
To process applications and to provide support, Zimmer Biomet or affiliated companies collect and electronically stores the data submitted by applicants. These data include personal information (name, address, date of birth, nationality, phone numbers and e-mail addresses and organization of the applicants) as well as information on the project. Zimmer Biomet may publish the names of the participating teams, their project titles, project videos and project abstracts on Zimmer Biomet websites, via social media, in press releases and in printed publications.
Following the completion the award ceremony, at the sole discretion of Zimmer Biomet, the winner of the Award and Zimmer Biomet will explore and discuss any possible future exclusive collaboration opportunities which are subject to negotiation and finalizing by the parties of an agreement containing mutually acceptable terms and conditions.
As Zimmer Biomet is interested in or attaches great value to digital innovations in musculoskeletal healthcare, following the completion of the Award ceremony and for a period of one (1) year after the Award ceremony, before the winner intends to sell an Innovation which has been submitted for this Award to a third party, the winner must first offer the Innovation and related rights to Zimmer Biomet on the same terms and conditions as they are offered by the third party. Zimmer Biomet will have ninety (90) days during which to accept said offer. If Zimmer Biomet does not accept said offer within said period, the winner shall be free to accept the third-party offer. If the applicant does not enter into an agreement with the third party on said terms and conditions and close the transaction within ninety (90) days, winners’ rights to sell the Innovation to the third party shall expire and the procedure described in this section shall again be applicable.